Delegates from the member boards of pharmacy adopted seven resolutions during the 118th National Association of Boards of Pharmacy® (NABP®) Annual Meeting, held in Phoenix, AZ, on May 19-21, 2022. The resolutions addressed the following:
- convening a task force to amend the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy to include a foundational definition of pharmacists as health care providers;
- conducting a survey of states and United States jurisdictions to collect data regarding pharmacy e-prescribing concerns and, if appropriate, convene a task force to further study the issue and make recommendations for improving e-prescribing functionality;
- examining the development of a national standardized pharmacy jurisprudence examination for the state boards of pharmacy to assess competence for licensure;
- requesting that Food and Drug Administration (FDA) provide timely guidance to states regarding how the agency intends to assess state licensing statutes, regulations, and processes for consistency with the agency’s National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers and that FDA focuses on issues impacting patient safety; and encouraging boards of pharmacy to provide public comment on the proposed rule;
- communicating with Drug Enforcement Administration (DEA) and Congress about the importance of state regulation of telepharmacy and the potential impact that DEA regulation could have on patient access to medications; and
- examining the feasibility of creating a system to allow efficient interstate portability through a multistate licensure compact.
Additionally, a recognition resolution honoring members of the Association who have passed away was unanimously approved.
The complete text of the resolutions will be available in the About section under Annual Meeting on the NABP website.